Jan is the Chief Medical Officer of Ventus Therapeutics. He brings more than 20 years of drug development experience within the pharmaceutical industry to Ventus. In his last role, Jan was the Senior Vice President and Development Unit Head for Neurology & Immunology at Merck KGaA/EMD Serono, overseeing and advancing a diverse portfolio of early- and late-stage compounds across multiple therapeutic areas. Prior to that, Jan spent 16 years in roles of increasing responsibility at Novartis, where he was instrumental in achieving regulatory approvals for first-in-class therapies such as fingolimod in multiple sclerosis, erenumab in migraine, and sacubitril-valsartan in heart failure. Jan obtained his M.D. from Hanover Medical School in Germany.
News
Making progress and achieving milestones to create innovative medicines

